Cargando…

Targeting the Alternative Vitamin E Metabolite Binding Site Enables Noncanonical PPARγ Modulation

[Image: see text] The lipid-sensing transcription factor PPARγ is the target of antidiabetic thiazolidinediones (TZD). At two sites within its ligand binding domain, it also binds oxidized vitamin E metabolites and the vitamin E mimetic garcinoic acid. While the canonical interaction within the TZD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arifi, Silvia, Marschner, Julian A., Pollinger, Julius, Isigkeit, Laura, Heitel, Pascal, Kaiser, Astrid, Obeser, Lennart, Höfner, Georg, Proschak, Ewgenij, Knapp, Stefan, Chaikuad, Apirat, Heering, Jan, Merk, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347545/ https://www.ncbi.nlm.nih.gov/pubmed/37385602 http://dx.doi.org/10.1021/jacs.3c03417

Ejemplares similares

Urate transporter inhibitor lesinurad is a selective peroxisome proliferator-activated receptor gamma modulator (sPPARγM) in vitro
por: Heitel, Pascal, et al.
Publicado: (2018)

Heterodimer formation with retinoic acid receptor RXRα modulates coactivator recruitment by peroxisome proliferator-activated receptor PPARγ
por: Kilu, Whitney, et al.
Publicado: (2021)

Activity Screening of Fatty Acid Mimetic Drugs Identified Nuclear Receptor Agonists
por: Helmstädter, Moritz, et al.
Publicado: (2022)

A Consensus Compound/Bioactivity Dataset for Data-Driven Drug Design and Chemogenomics
por: Isigkeit, Laura, et al.
Publicado: (2022)

Comprehensive Set of Tertiary Complex Structures and Palmitic Acid Binding Provide Molecular Insights into Ligand Design for RXR Isoforms
por: Chaikuad, Apirat, et al.
Publicado: (2020)

Structural Insights into Plasticity and Discovery of Remdesivir Metabolite GS-441524 Binding in SARS-CoV-2 Macrodomain
por: Ni, Xiaomin, et al.
Publicado: (2021)

Systematic Assessment of Fragment Identification for Multitarget Drug Design
por: Brunst, Steffen, et al.
Publicado: (2021)

Allosteric modulation of the farnesoid X receptor by a small molecule
por: Gabler, Matthias, et al.
Publicado: (2018)

Dual Farnesoid X Receptor/Soluble Epoxide Hydrolase Modulators Derived from Zafirlukast
por: Schierle, Simone, et al.
Publicado: (2019)

The orphan nuclear receptor Nurr1 is responsive to non-steroidal anti-inflammatory drugs
por: Willems, Sabine, et al.
Publicado: (2020)

Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries
por: Willems, Sabine, et al.
Publicado: (2022)

Chemical Starting Matter for HNF4α Ligand Discovery and Chemogenomics
por: Meijer, Isabelle, et al.
Publicado: (2020)

Kernel learning for ligand-based virtual screening: discovery of a new PPARγ agonist
por: Rupp, Matthias, et al.
Publicado: (2010)

A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in mice
por: Heitel, Pascal, et al.
Publicado: (2020)

Druggability Evaluation of the Neuron Derived Orphan Receptor (NOR‐1) Reveals Inverse NOR‐1 Agonists
por: Zaienne, Daniel, et al.
Publicado: (2022)

Zafirlukast Is a Dual Modulator of Human Soluble Epoxide Hydrolase and Peroxisome Proliferator-Activated Receptor γ
por: Göbel, Tamara, et al.
Publicado: (2019)

In silico polypharmacology: retrospective recognition vs. rational design
por: Proschak, Ewgenij
Publicado: (2014)

Comparative structural analyses and nucleotide-binding characterization of the four KH domains of FUBP1
por: Ni, Xiaomin, et al.
Publicado: (2020)

Defined PEG smears as an alternative approach to enhance the search for crystallization conditions and crystal-quality improvement in reduced screens
por: Chaikuad, Apirat, et al.
Publicado: (2015)

Comparative structural analyses of the NHL domains from the human E3 ligase TRIM–NHL family
por: Chaikuad, Apirat, et al.
Publicado: (2022)

Structural insights into a regulatory mechanism of FIR RRM1–FUSE interaction
por: Ni, Xiaomin, et al.
Publicado: (2023)

PocketPicker: analysis of ligand binding-sites with shape descriptors
por: Weisel, Martin, et al.
Publicado: (2007)

A noncanonical PPARγ/RXRα-binding sequence regulates leptin expression in response to changes in adipose tissue mass
por: Zhang, Yinxin, et al.
Publicado: (2018)

Assessing reversible and irreversible binding effects of kinase covalent inhibitors through ADP-Glo assays
por: Schröder, Martin, et al.
Publicado: (2021)

Development and in vitro Profiling of Dual FXR/LTA4H Modulators
por: Schierle, Simone, et al.
Publicado: (2021)

SBE13, a newly identified inhibitor of inactive polo-like kinase 1
por: Keppner, Sarah, et al.
Publicado: (2010)

Multi-Target Approaches in Metabolic Syndrome
por: Lillich, Felix F., et al.
Publicado: (2021)

Conservation of structure and activity in Plasmodium purine nucleoside phosphorylases
por: Chaikuad, Apirat, et al.
Publicado: (2009)

A unique inhibitor binding site in ERK1/2 is associated with slow binding kinetics
por: Chaikuad, Apirat, et al.
Publicado: (2014)

Image-Based Annotation of Chemogenomic Libraries for Phenotypic Screening
por: Tjaden, Amelie, et al.
Publicado: (2022)

Mutation in the Common Docking Domain Affects MAP Kinase ERK2 Catalysis and Stability
por: Novak, Leonore, et al.
Publicado: (2023)

A Diverse Benchmark Based on 3D Matched Molecular Pairs for Validating Scoring Functions
por: Kalinowsky, Lena, et al.
Publicado: (2018)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition—The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine
por: Wurzlbauer, Anne, et al.
Publicado: (2020)

7-(2-Anilinopyrimidin-4-yl)-1-benzazepin-2-ones Designed by a “Cut and Glue” Strategy Are Dual Aurora A/VEGF-R Kinase Inhibitors
por: Karatas, Mehmet, et al.
Publicado: (2021)

Crystal Structure and Inhibitor Identifications Reveal Targeting Opportunity for the Atypical MAPK Kinase ERK3
por: Schröder, Martin, et al.
Publicado: (2020)

Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK
por: Forster, Michael, et al.
Publicado: (2020)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_nnv7cqamo5m5uaq76pebf8kmvh